Asthma is a serious public health problem. It is one of the top five chronic diseases globally, along with heart disease, stroke, cancer and diabetes. More than 22 million Americans suffer from asthma. Each year, complications from asthma attacks result in approximately:
- 13.6 million unscheduled doctor office visits
- 1.8 million emergency room visits
- 500,000 hospitalizations
- 4,000 deaths
Bronchial thermoplasty, delivered by the Alair® System, is a non-sedated bronchoscopic procedure for long-lasting control of severe asthma, 365 days a year. The treatment is comprised of three bronchoscopies spread over six-to-nine-week period. This procedure is designed for severe persistent asthma in patients 18 years and older whose asthma is not well-controlled with inhaled corticosteroids and long-acting beta-agonists.